Fulcrum Therapeutics Inc (FULC)
3.82
+0.16
(+4.23%)
USD |
NASDAQ |
Oct 04, 16:00
3.81
-0.01
(-0.26%)
After-Hours: 20:00
Fulcrum Therapeutics Shareholders Equity (Annual): 235.19M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 235.19M |
| December 31, 2022 | 198.94M |
| December 31, 2021 | 211.54M |
| December 31, 2020 | 95.18M |
| Date | Value |
|---|---|
| December 31, 2019 | 87.15M |
| December 31, 2018 | 76.00M |
| December 31, 2017 | 1.322M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
87.15M
Minimum
2019
235.19M
Maximum
2023
165.60M
Average
198.94M
Median
2022
Shareholders Equity (Annual) Benchmarks
| Bioventus Inc | 173.59M |
| Arcturus Therapeutics Holdings Inc | 278.51M |
| Entrada Therapeutics Inc | 242.36M |
| Johnson & Johnson | 68.77B |
| Insmed Inc | -331.92M |